Arlcyn 150 Tablet

Visão geral do produto

About Arlcyn 150 Tablet

Arlcyn 150 Tablet is a medication containing the active ingredient Erlotinib, classified as Medication for treatment of non-small-cell lung cancer. Erlotinib, sold under the brand name Tarceva among others, is a medication used to treat non-small cell lung cancer (NSCLC) and pancreatic cancer.

Key Benefits & Uses

• Used for: 1 INDICATIONS AND USAGE Erlotinib tablet is a kinase inhibitor indicated for: The treatment of patients with metastatic non-small cell lung cancer.
• Use only as directed on the product label or by a healthcare professional.
• Follow the authorised product information for dosing and duration of use.

Active Ingredient & Action

Erlotinib, the active ingredient in Arlcyn 150 Tablet, belongs to the Medication for treatment of non-small-cell lung cancer class. 1 INDICATIONS AND USAGE Erlotinib tablet is a kinase inhibitor indicated for: The treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations as detected by an FDA-approved test receiving. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Arlcyn 150 Tablet. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Arlcyn 150 Tablet for extended periods without medical advice.